Your browser doesn't support javascript.
loading
MAIT cell activation augments adenovirus vector vaccine immunogenicity.
Provine, Nicholas M; Amini, Ali; Garner, Lucy C; Spencer, Alexandra J; Dold, Christina; Hutchings, Claire; Silva Reyes, Laura; FitzPatrick, Michael E B; Chinnakannan, Senthil; Oguti, Blanche; Raymond, Meriel; Ulaszewska, Marta; Troise, Fulvia; Sharpe, Hannah; Morgan, Sophie B; Hinks, Timothy S C; Lambe, Teresa; Capone, Stefania; Folgori, Antonella; Barnes, Eleanor; Rollier, Christine S; Pollard, Andrew J; Klenerman, Paul.
Afiliação
  • Provine NM; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK. nicholas.provine@ndm.ox.ac.uk paul.klenerman@ndm.ox.ac.uk.
  • Amini A; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Garner LC; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Spencer AJ; Jenner Institute, University of Oxford, Oxford, UK.
  • Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.
  • Hutchings C; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
  • Silva Reyes L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.
  • FitzPatrick MEB; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Chinnakannan S; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
  • Oguti B; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.
  • Raymond M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.
  • Ulaszewska M; Jenner Institute, University of Oxford, Oxford, UK.
  • Troise F; Nouscom, SRL, Rome, Italy.
  • Sharpe H; Ceinge Biotechnologie Avanzate, Naples, Italy.
  • Morgan SB; Jenner Institute, University of Oxford, Oxford, UK.
  • Hinks TSC; Respiratory Medicine Unit, Nuffield Department of Medicine - Experimental Medicine, University of Oxford, Oxford, UK.
  • Lambe T; Respiratory Medicine Unit, Nuffield Department of Medicine - Experimental Medicine, University of Oxford, Oxford, UK.
  • Capone S; Jenner Institute, University of Oxford, Oxford, UK.
  • Folgori A; ReiThera, SRL, Rome, Italy.
  • Barnes E; ReiThera, SRL, Rome, Italy.
  • Rollier CS; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Pollard AJ; Jenner Institute, University of Oxford, Oxford, UK.
  • Klenerman P; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
Science ; 371(6528): 521-526, 2021 01 29.
Article em En | MEDLINE | ID: mdl-33510029
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Adenoviridae / Células T Invariantes Associadas à Mucosa / Imunogenicidade da Vacina Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Science Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Adenoviridae / Células T Invariantes Associadas à Mucosa / Imunogenicidade da Vacina Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Science Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos